About NewAmsterdam Pharma Co. NV 
NewAmsterdam Pharma Co. NV
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 36 Schemes (23.71%)
Foreign Institutions
Held by 93 Foreign Institutions (21.14%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
3 Million
(Quarterly Results - Mar 2026)
Net Profit:
-48 Million
Pharmaceuticals & Biotechnology
USD 3,447 Million (Small Cap)
NA (Loss Making)
NA
0.00%
-0.93
-27.07%
5.04






